PAR 3.77% 25.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-69

  1. 4,246 Posts.
    lightbulb Created with Sketch. 6727
    It is bizarre that this drug wasnt thought about for human use until 'now', well the first human use/testing for arthritis was back in 2010 but it is amazing there havent been more companies trying to get this onto market, of course its locked and patented now for us...but its surprising it has taken so long... extract below from Whitta's post of Greencross. I actually invested in Greencross a long time and got out of most of my holdings once it started to run down with the management change over, got a bit messy. Luckily I got in early enough to enjoy some profits. I didn't even know or ever hear about arthritis in cats/dogs through my investment in Greencross, it shouldn't really surprise us that PAR isnt well known...yet. Read the extract below, its the same as what we have experienced over the last 6 - 8 months in terms of effects and what has been reported on through various announcements by PAR.


    https://hotcopper.com.au/data/attachments/1719/1719269-948cc9d2c7fd555917062f2d19354c04.jpg

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
25.5¢
Change
-0.010(3.77%)
Mkt cap ! $89.19M
Open High Low Value Volume
27.0¢ 27.0¢ 25.5¢ $162.7K 620.9K

Buyers (Bids)

No. Vol. Price($)
2 25008 25.5¢
 

Sellers (Offers)

Price($) Vol. No.
26.0¢ 34768 1
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.